Markets市場

ProLogium Files Initial F-4 as TDAC De-SPAC Transaction Moves Into SEC Review

Translational Development Acquisition Company (NYSE: TDAC) announced July 6 that ProLogium has submitted an initial F-4 registration statement to the U.S. Securities and Exchange Commission, placing the planned merger formally…

By Nadia Petrova·July 6, 2026·二〇二六年七月六日·2 min read